@Article{Rybakowski2007,
journal="Przewodnik Lekarza/Guide for GPs",
issn="1505-8409",
year="2007",
title="Recent advances in pharmacological treatment of psychiatric disorders",
abstract="During over half a century of contemporary psychopharmacology, five groups of psychotropic drugs have evolved, with therapeutic action on specific psychopathological states. They include: 1) antipsychotic (neuroleptic) drugs, with therapeutic action on psychotic symptoms such as delusions and hallucinations; 2) antidepressant drugs, exerting therapeutic action on depressive symptoms; 3) mood-stabilizing drugs, preventing manic and depressive recurrences in bipolar affective illness; 4) anxiolytic (anti-anxiety) drugs, having anti-anxiety and anti-stress properties; and 5) pro-cognitive (anti-dementia) drugs, causing an improvement of cognitive functions, especially memory. In the present paper, the use of these drugs in the therapy of psychiatric disorders is presented from a historical perspective and in the light of recent advances in clinical psychopharmacology at the beginning of the 21st century.",
author="Rybakowski, Janusz",
pages="224--231",
url="https://www.termedia.pl/Recent-advances-in-pharmacological-treatment-of-psychiatric-disorders,8,7778,1,1.html"
}